Series C funding round for LifeMine Therapeutics raising $180M in March 2022
Series C funding round for LifeMine Therapeutics raising $180M in March 2022
| Investor | Firm Type |
|---|
| Partner |
|---|
FidelityLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$300M
Top Valuation
-
LifeMine Therapeutics raised $180M in a Series C round.
The round was announced on 03/01/22.
The round was led by Fidelity Management & Research Company.